AU7983691A - 1h-substituted-imidazo{4,5-d}pyridazine compounds for treatment of cardiovascular disorders - Google Patents
1h-substituted-imidazo{4,5-d}pyridazine compounds for treatment of cardiovascular disordersInfo
- Publication number
- AU7983691A AU7983691A AU79836/91A AU7983691A AU7983691A AU 7983691 A AU7983691 A AU 7983691A AU 79836/91 A AU79836/91 A AU 79836/91A AU 7983691 A AU7983691 A AU 7983691A AU 7983691 A AU7983691 A AU 7983691A
- Authority
- AU
- Australia
- Prior art keywords
- imidazo
- substituted
- treatment
- cardiovascular disorders
- pyridazine compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53887990A | 1990-06-15 | 1990-06-15 | |
US538879 | 1990-06-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7983691A true AU7983691A (en) | 1992-01-07 |
Family
ID=24148809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU79836/91A Abandoned AU7983691A (en) | 1990-06-15 | 1991-06-07 | 1h-substituted-imidazo{4,5-d}pyridazine compounds for treatment of cardiovascular disorders |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU7983691A (en) |
WO (1) | WO1991019715A1 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5616599A (en) * | 1991-02-21 | 1997-04-01 | Sankyo Company, Limited | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
WO1993003033A1 (en) * | 1991-07-26 | 1993-02-18 | G. D. Searle & Co. | CARBONATE-SUBSTITUTED IMIDAZO[4,5-d] PYRIDAZINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS |
US5442062A (en) * | 1991-10-24 | 1995-08-15 | The Upjohn Company | Imidazole derivatives and pharmaceutical compositions containing the same |
WO1993018035A1 (en) * | 1992-03-04 | 1993-09-16 | Abbott Laboratories | Angiotensin ii receptor antagonists |
CA2111662C (en) * | 1992-12-17 | 2004-11-23 | Hiroaki Yanagisawa | Biphenyl derivatives, their preparation and their use for the treatment of hypertension and cardiac disease |
SK179899A3 (en) | 1997-07-03 | 2001-12-03 | Du Pont Pharm Co | Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders |
US6124463A (en) * | 1998-07-02 | 2000-09-26 | Dupont Pharmaceuticals | Benzimidazoles as corticotropin release factor antagonists |
US6271380B1 (en) * | 1998-12-30 | 2001-08-07 | Dupont Pharmaceuticals Company | 1H-imidazo[4,5-d]pyridazin-7-ones, 3H-imidazo-[4,5-c]pyridin-4-ones and corresponding thiones as corticotropin releasing factor (CRF) receptor ligands |
SE9903028D0 (en) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
US7232823B2 (en) * | 2003-06-09 | 2007-06-19 | Pfizer, Inc. | Cannabinoid receptor ligands and uses thereof |
CN101772513B (en) | 2007-06-04 | 2013-11-13 | 协同医药品公司 | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
AU2009256157B2 (en) | 2008-06-04 | 2014-12-18 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
JP2011528375A (en) | 2008-07-16 | 2011-11-17 | シナジー ファーマシューティカルズ インコーポレイテッド | Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer, and other disorders |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
US9486494B2 (en) | 2013-03-15 | 2016-11-08 | Synergy Pharmaceuticals, Inc. | Compositions useful for the treatment of gastrointestinal disorders |
US9708367B2 (en) | 2013-03-15 | 2017-07-18 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
CA2913737A1 (en) | 2013-06-05 | 2014-12-11 | Synergy Pharmaceuticals, Inc. | Ultra-pure agonists of guanylate cyclase c, method of making and using same |
CA3210501A1 (en) * | 2021-02-03 | 2022-08-11 | Sanofi | Derivatives of imidazo[4,5-d]pyridazine, their preparation and their therapeutic application |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1334092C (en) * | 1986-07-11 | 1995-01-24 | David John Carini | Angiotensin ii receptor blocking imidazoles |
US4880804A (en) * | 1988-01-07 | 1989-11-14 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking benzimidazoles |
IE64514B1 (en) * | 1989-05-23 | 1995-08-09 | Zeneca Ltd | Azaindenes |
IL94390A (en) * | 1989-05-30 | 1996-03-31 | Merck & Co Inc | Di-substituted imidazo fused 6-membered nitrogen-containing heterocycles and pharmaceutical compositions containing them |
EP0415886A3 (en) * | 1989-08-30 | 1991-10-23 | Ciba-Geigy Ag | Aza compounds |
-
1991
- 1991-06-07 AU AU79836/91A patent/AU7983691A/en not_active Abandoned
- 1991-06-07 WO PCT/US1991/003907 patent/WO1991019715A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO1991019715A1 (en) | 1991-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7983691A (en) | 1h-substituted-imidazo{4,5-d}pyridazine compounds for treatment of cardiovascular disorders | |
AU1687592A (en) | 5-arylheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders | |
AUPM864894A0 (en) | Treatment of bowel-dependent neurological disorders | |
AU639192B2 (en) | Treatment of water | |
IN172468B (en) | ||
AU644448B2 (en) | Process for the preparation of flavouring mixtures | |
AU7903091A (en) | N-substituted-1,2,4-triazolone compounds for treatment of cardiovascular disorders | |
AU2338992A (en) | Carbonate-substituted imidazo(4,5-d) pyridazine compounds for treatment of cardiovascular disorders | |
AU1674492A (en) | Alzheimer's disease treatment with tacrine metabolites | |
AU8656491A (en) | 1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders | |
AU9024591A (en) | Biphenylalkyl xanthine compounds for treatment of cardiovascular disorders | |
EP0470462A3 (en) | Process for the preparation of halogenated methylketones, especially 1,1,1-trifluoracetone | |
AU5518694A (en) | Treatment of a group of related disorders | |
EP0557949A3 (en) | Process for the preparation of 2,4,5 trifluorobenzonitrile | |
HU9503959D0 (en) | Process for the preparation of substituted 4,6-diamino-5-cyanopyrimidines | |
AU8185491A (en) | Treatment of disease | |
AU1807592A (en) | New combination preparation for treatment of parkinson's disease | |
EP0534449A3 (en) | Process for the preparation of 3-aminomethyl-3,5,5-trialkylcyclohexylamine | |
AU2297192A (en) | Optically pure s(-) nadolol for treatment of cardiovascular disorders | |
EP0475272A3 (en) | Process for the preparation of 2,3,5-trimethyl-p-benzoquinone | |
HU905312D0 (en) | Preparation for the treating of psoriasis topicalis | |
EP0538686A3 (en) | Process for the preparation of 2,2,-bis-hydroxymethyl-butanediol-(1,4) | |
AU1875688A (en) | Treatment of cerebral disorders | |
EP0579077A3 (en) | 1,3,4-thiadiazinones for the treatment of cardiovascular diseases | |
EP0530696A3 (en) | Process for the preparation of pentane 1,5-diamines |